Cytek Biosciences Investors

28 investors on Angel Roster list Cytek Biosciences in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, China and Israel.

Investors are matched on the company name in their portfolio, so companies that share the name Cytek Biosciences can appear together.

Investors listed
28
With verified email
36%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 28 Cytek Biosciences investors

The most complete profiles first. Showing 28 of 28.

  • David BonitaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more

    Verified email available

  • Geoffrey HsuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • He HUANGVerified

    Venture Capital, Entrepreneurship Program, Private Equity Firm · China

    Early Stage VentureHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Maihaoche.com, Yunshan Networks, OURS Technology, Ting Ting Chang Guwen and 67 more

    Contact details available

  • Figo ZhangVerified

    Venture Capital · China

    Health CareWomen FoundedLife ScienceEducation

    Portfolio: Maihaoche.com, Yunshan Networks, OURS Technology, Ting Ting Chang Guwen and 67 more

    Verified email available

  • Jonathan SilversteinVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan WangVerified

    Private Equity Firm · China

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Lei YangVerified

    Venture Capital · China

    Health CareWomen FoundedLife ScienceEducation

    Portfolio: Maihaoche.com, Yunshan Networks, OURS Technology, Ting Ting Chang Guwen and 67 more

    Verified email available

  • Rishi GuptaVerified

    Private Equity Firm · United States

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Sean LinVerified

    Venture Capital · China

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: Zhangkong Tangniaobing, Aohua, ImmuneOnco Biopharma, Cytek Biosciences and 14 more

    Verified email available

  • Tony WuVerified

    Venture Capital · Hong Kong

    Health CareWomen FoundedLife ScienceEducation

    Portfolio: Maihaoche.com, Yunshan Networks, OURS Technology, Ting Ting Chang Guwen and 67 more

    Verified email available

  • Yan KeVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceEducation

    Portfolio: Maihaoche.com, Yunshan Networks, OURS Technology, Ting Ting Chang Guwen and 67 more

    Contact details available

  • Yao HoVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: Zhangkong Tangniaobing, Aohua, ImmuneOnco Biopharma, Cytek Biosciences and 14 more

    Verified email available

  • Carter Neild

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Chau Khuong

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more

    Contact details available

  • Fiona Yu

    Venture Capital, Entrepreneurship Program, Private Equity Firm · China

    Early Stage VentureHealth CareWomen FoundedEnterprise SoftwareLife Science

    Portfolio: Maihaoche.com, Yunshan Networks, OURS Technology, Ting Ting Chang Guwen and 67 more

    Contact details available

  • Francine Fang

    Venture Capital, Investor · China

    SeedHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: Subtle Medical, Cytek Biosciences, Refuge Biotechnologies, Ansun BioPharma and 14 more

    Contact details available

  • Joy Y.

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceArtificial Intelligence (AI)

    Portfolio: Subtle Medical, Cytek Biosciences, Refuge Biotechnologies, Ansun BioPharma and 14 more

    Contact details available

  • Scotland Stevens

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Anat Naschitz

    Private Equity Firm · Israel

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Chen Long William

    Venture Capital, Private Equity Firm · China

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: Zhangkong Tangniaobing, Aohua, ImmuneOnco Biopharma, Cytek Biosciences and 14 more

    Contact details available

  • Derek Yuan, Ph.D.

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: Zhangkong Tangniaobing, Aohua, ImmuneOnco Biopharma, Cytek Biosciences and 14 more

    Contact details available

  • Erez Chimovits

    Private Equity Firm · Israel

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • James Zhao

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsTrading PlatformLife Science

    Portfolio: Zhangkong Tangniaobing, Aohua, ImmuneOnco Biopharma, Cytek Biosciences and 14 more

    Contact details available

  • Jing Xu, Ph.D

    Venture Capital, Private Equity Firm · Singapore

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: Zhangkong Tangniaobing, Aohua, ImmuneOnco Biopharma, Cytek Biosciences and 14 more

    Contact details available

  • Keting Chu

    Venture Capital · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: Zhangkong Tangniaobing, Aohua, ImmuneOnco Biopharma, Cytek Biosciences and 14 more

    Contact details available

  • Lixin Li

    Venture Capital · China

    Health CareWomen FoundedLife ScienceEducation

    Portfolio: Maihaoche.com, Yunshan Networks, OURS Technology, Ting Ting Chang Guwen and 67 more

    Contact details available

  • Lu Lin

    Venture Capital · China

    Health CareWomen FoundedLife ScienceEducation

    Portfolio: Maihaoche.com, Yunshan Networks, OURS Technology, Ting Ting Chang Guwen and 67 more

    Contact details available

  • Zoe Ding

    Venture Capital · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: Zhangkong Tangniaobing, Aohua, ImmuneOnco Biopharma, Cytek Biosciences and 14 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Cytek Biosciences investors are on Angel Roster?

Angel Roster lists 28 Cytek Biosciences investors. 10 of them (36%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (23), Private Equity Firms (17) and Entrepreneurship Programs (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Cytek Biosciences investors invest in?

Among those that list a stage, the most common are Seed (7), Series A (5) and Early Stage Venture (2).

Where are Cytek Biosciences investors based?

Most are based in the United States (14), China (10) and Israel (2).

Which companies have Cytek Biosciences investors backed?

The most-backed portfolio companies among them are Nucleix (18), Cullinan Oncology (10), Ansun BioPharma (10), Abbisko Therapeutics (10) and Immvira (10).

How do I contact Cytek Biosciences investors?

Create a free Angel Roster account to search and filter all 28, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.